about us | newsletter | contact | archive | members area
AURELIA COSTACHE, EY
There have been initiatives in the industry to pilot the leverage upon digital informati»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  2017 Views
Daily Info
Helios Phoenix extends on Romanian market by acquiring Millenium Logistic Park

Greek developer Helios Phoenix extends its Romanian portfolio by acquiring Millenium Logistic Park. The industrial park located in Popesti Leordeni with 12,000 sqm of warehous...

NATO to spend three billion Euro on cyber defence

NATO plans to spend three billion Euro to upgrade its satellite and computer technology over the next three years as the Western military alliance adapts to new threats, a sen...

Office stock to increase by 350,000 sqm this year, says Colliers

Romanian office market registered last year the highest rate of deliveries in the last seven years, and the upward trend will continue in 2017. This year, the stock of office ...

VIG profit doubled to around 407 million Euro last year

Vienna Insurance Group (VIG) profit before taxes more than doubled to around 407 million Euro last year, according to preliminary figures for 2016.

Enel to invest 329 million Euro in Romania in 2017-2018

Enel has planned investments for a total of 329 million Euro for the current regulatory cycle ending in 2018, of which of over 151 million Euro are due for 2017 and 178 millio...

 
 
   
advertising

advertising

advertising

advertising

advertising

advertising

More on News
Energy Performance Contracting for public buildings

The Romanian Association for Promoting Energy Efficiency (ARPEE), established in 2012, has as overall scope the mobilization of its members’ resources and competences to ...

President Iohannis wants to address Parliament on 7 February

President Klaus Iohannis sent a letter to the Heads of the two Chambers of the Legislature, in which he reveals that he wants to address Parliament on 7 February, in respec...

Iohannis at Government meeting: I discussed with the PM; I am pleased with how you do your job

President Klaus Iohannis said on Wednesday he had, before the Government meeting, a "very applied" discussion with Prime Minister Sorin Grindeanu, and the head of state tol...

SRI and DNA have no protocol, says SRI Spokesman

Spokesman of the Romanian Intelligence Service (SRI) Ovidiu Marincea stated that the SRI does not have any protocol with the National Anticorruption Directorate (DNA), but ...

Iohannis: 2017 budget is a problematic and risky one

President Klaus Iohannis said that the budget draft for 2017 is a problematic and risky one, pointing that there is the real risk for the deficit of three percent to be exc...

PM Grindeanu: We support our views on 2017 budget

The Government will support its views in respect to the 2017 budget draft in the Supreme Council for National Defence (CSAT) meeting on Tuesday, Prime Minister Sorin Grinde...

PM Grindeanu wishes for 2019 with no CVM for Romania

Premier Sorin Grindeanu stated, on Thursday, at the headquarters of the European Commission, that he wishes in 2019 the Cooperation and Verification Mechanism (CVM) for Rom...